Global X China Biotech ETF (HKG:2820)
81.14
+3.14 (4.03%)
Sep 1, 2025, 3:58 PM HKT
HKG:2820 Holdings Information
HKG:2820 is an equity ETF with a total of 30 individual holdings. The top holdings are WuXi AppTec stock at 10.04%, WuXi Biologics at 9.33%, BeOne Medicines at 9.11%, Innovent Biologics at 9.02%, and Jiangsu Hengrui Medicine at 8.74%.
Total Holdings
30
Top 10 Percentage
68.87%
Asset Class
Equity
ETF Category
Health Care
Assets
572.64M
PE Ratio
33.92
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | SHA: 603259 | WuXi AppTec Co., Ltd. | 10.04% |
2 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 9.33% |
3 | ONC | BeOne Medicines Ltd. | 9.11% |
4 | HKG: 1801 | Innovent Biologics, Inc. | 9.02% |
5 | SHA: 600276 | Jiangsu Hengrui Medicine Co., Ltd. | 8.74% |
6 | HKG: 9926 | Akeso, Inc. | 6.94% |
7 | HKG: 1177 | Sino Biopharmaceutical Limited | 5.90% |
8 | HKG: 1530 | 3SBio Inc. | 3.87% |
9 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 3.14% |
10 | SHE: 002252 | Shanghai RAAS Blood Products Co., Ltd. | 2.79% |
11 | ZLAB | Zai Lab Limited | 2.52% |
12 | SHA: 688331 | RemeGen Co., Ltd. | 2.18% |
13 | SHE: 300759 | Pharmaron Beijing Co., Ltd. | 2.01% |
14 | SHE: 300255 | Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | 2.00% |
15 | SHA: 688578 | Shanghai Allist Pharmaceuticals Co., Ltd. | 1.90% |
16 | SHA: 603087 | Gan & Lee Pharmaceuticals. | 1.88% |
17 | SHA: 688506 | Sichuan Biokin Pharmaceutical Co.,Ltd. | 1.81% |
18 | SHA: 688114 | MGI Tech Co., Ltd. | 1.75% |
19 | SHE: 300347 | Hangzhou Tigermed Consulting Co., Ltd | 1.63% |
20 | HKG: 1548 | Genscript Biotech Corporation | 1.59% |
21 | SHA: 600161 | Beijing Tiantan Biological Products Co., Ltd. | 1.58% |
22 | SHA: 688180 | Shanghai Junshi Biosciences Co., Ltd. | 1.41% |
23 | SHE: 002007 | Hualan Biological Engineering Inc. | 1.39% |
24 | HKG: 0867 | China Medical System Holdings Limited | 1.29% |
25 | SHA: 603392 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | 1.26% |
As of Aug 29, 2025